REQUOLIS Trademark

Trademark Overview


On Tuesday, March 22, 2016, a trademark application was filed for REQUOLIS with the United States Patent and Trademark Office. The USPTO has given the REQUOLIS trademark a serial number of 79188748. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Thursday, September 22, 2022. This trademark is owned by Novartis AG. The REQUOLIS trademark is filed in the Pharmaceutical Products category with the following description:

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; anti-fungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculoskeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the preven...
requolis

General Information


Serial Number79188748
Word MarkREQUOLIS
Filing DateTuesday, March 22, 2016
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateThursday, September 22, 2022
Registration Number5070828
Registration DateTuesday, November 1, 2016
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 16, 2016

Trademark Statements


Goods and ServicesAnti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; anti-fungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculoskeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of respiratory diseases and asthma
Translation of Words in MarkThe wording "REQUOLIS" has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeH - NOT AVAILABLE
Class Status DateMonday, January 13, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNovartis AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCH

Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCH

Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCH

Trademark Events


Event DateEvent Description
Wednesday, April 12, 2023NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Tuesday, April 11, 2023DEATH OF INTERNATIONAL REGISTRATION
Friday, October 2, 2020NOTIFICATION PROCESSED BY IB
Friday, January 31, 2020NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Friday, January 31, 2020DEATH OF INTERNATIONAL REGISTRATION
Friday, June 9, 2017NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Friday, December 23, 2016NOTIFICATION PROCESSED BY IB
Friday, December 2, 2016FINAL DISPOSITION NOTICE SENT TO IB
Friday, December 2, 2016FINAL DISPOSITION PROCESSED
Thursday, December 1, 2016GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Tuesday, November 1, 2016REGISTERED-PRINCIPAL REGISTER
Tuesday, August 16, 2016PUBLISHED FOR OPPOSITION
Wednesday, August 10, 2016NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, August 10, 2016NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, July 27, 2016NOTICE OF PUBLICATION
Friday, July 15, 2016APPLICATION FILING RECEIPT MAILED
Monday, July 11, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, July 11, 2016ASSIGNED TO EXAMINER
Monday, July 11, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, July 8, 2016LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, July 7, 2016SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB